Acute myeloid leukaemia+1
Not yet recruitingStudy on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure
Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure
- Disease:Acute myeloid leukaemiaMyelodysplastic syndrome
- Substances:HydrocortisoneImetelstat Sodium+2
France- Participants:18–64 years · 65+ years
- Substances:Hydrocortisone
- Sponsor:Gcp-Service International West GmbH











